NOCD announced a $34M financing round co-led by Cigna Ventures and 7wireVentures, with participation from new investor Longitude Capital and existing investors Kaiser Permanente Ventures, F-Prime Capital, Eight Roads Capital, and Health Enterprise Partners.
The round was backed by investors such as F-Prime, 8-Roads, Kaiser Permanente Ventures, 7wireVentures, Chicago Ventures, and Health Enterprise Partners.
A sudden onset of obsessive-compulsive disorder derailed Stephen Smith’s college football career. Now the CEO of an OCD treatment program, he shares what he wished he knew about this debilitating yet treatable condition.
7wireVentures had the pleasure of sitting down with Stephen Smith, Founder and CEO of NOCD. Continue reading to learn how Stephen’s personal experience recovering from OCD inspired him to start NOCD and help the 1 in every 40 people with OCD around the world access high quality care.
Stephen Smith, CEO of NOCD, talks about the increase of OCD therapy sessions since the outbreak of COVID-19.
7wireVentures portfolio company NOCD has seen the number of people using its platform double since the Covid-19 pandemic started.
7wireVentures portfolio company NOCD sees big increase during Coronavirus.
7wireVentures portfolio company NOCD shares how the new environment impacts people with OCD.
7wireVentures portfolio company NOCD provides additional relief through virtual treatment for many triggered by COVID-19.